TScan Therapeutics, Inc. (TCRX)
NASDAQ·Healthcare·Biotechnology
$1.27
-3.44%
Mkt Cap $73.13M
Next Earnings
In 6 daysTue, May 5, 2026
EPS Estimate
-$0.22
4 analysts
Revenue Estimate
$2.50M
Last quarter: beat by +33.33% on EPS, +5.40% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$73.13M
P/E
—
Fwd P/E
—
P/S
6.82
Rev TTM
—
EPS TTM
-$1.00